Andromeda Biotech has entered into an agreement with Teva Pharmaceutical Ltd (ADR) (NYSE:TEVA) Industries for the acquisition of Teva’s rights for Andromeda’s drug, DiaPep277, for the treatment of type 1 diabetes. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $48.07 in last session, and closed at $48.33, while the day range of stock is $48.03 – $48.84. The stock showed a positive weekly performance of 6.59%.
JPMorgan Chase & Co. upgraded shares of Novo Nordisk (NYSE:NVO) from an underweight rating to an overweight rating in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports. Novo Nordisk A/S (ADR) (NYSE:NVO) stock opened at $47.11, in last session and closed at $48.23, by gaining 5.26%. The 52 week range of the stock is $29.90 – $48.42. Company’s market capitalization is $128.08 billion.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that Vascepa was given three years of marketing exclusivity by the U.S. Food and Drug Administration (FDA) in connection with the MARINE indication. Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock decreased -2.65% and finished the last session at $1.84. The EPS of the stock remained -1.03. Company’s market capitalization is $317.66 million.
Endo Health Solutions Inc (NASDAQ:ENDP) reached a resolution of criminal and civil claims with the federal and relevant state authorities and the District of Columbia pertaining to the illegal marketing of the company’s painkiller Lidoderm. Endo will have to shell out payments upto $194 million to settle the dispute. Endo had already set aside the amount to cover the penalties on Lidoderm. Endo Health Solutions Inc (NASDAQ:ENDP) stock opened the session at $78.98, and closed the session at $77.72. The 52 week range of the stock remained $27.88 – $79.89 and the day range was $76.67 – $79.30.